Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197
about
Dendrimer advances for the central nervous system delivery of therapeuticsProtein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in miceClostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice.Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B StreptococcusHaemophilus influenzae type b conjugate vaccines.Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity.The human antibody V region repertoire to the type B capsular polysaccharide of Haemophilus influenzae.Cancer vaccines and carbohydrate epitopes.Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linkerEffects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugatesThe repertoire of human antibody to the Haemophilus influenzae type b capsular polysaccharide.Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.Identification of a single amino acid substitution in the diphtheria toxin A chain of CRM 228 responsible for the loss of enzymatic activity.Vaccines based on the cell surface carbohydrates of pathogenic bacteria.Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protectionBlood-brain barrier transport of therapeutics via receptor-mediationConjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune responseRationale and prospects for novel pneumococcal vaccines.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants.
P2860
Q26828423-DAD2C70F-FD25-4509-8F58-9991CB133BFDQ28343287-06636527-44B1-4A7B-AE40-7444BD70A365Q34001884-3F7A9E7F-B86C-4537-A58E-A4FF8999507DQ34002272-F839ED1A-4E38-413E-8392-2D8776D3C5E7Q34003957-4DCD12BB-9BF5-4AB2-923F-497EE4AC1D72Q34006223-CFFDFAC5-7484-4A89-812B-E1F5B9652BE1Q34170021-EED97DE2-ADDA-42E3-9EDE-782548DEBC9FQ34262847-315F11AB-0E43-4183-9FF2-D68B0343FC39Q34349892-4D9DE792-466B-4B90-94C3-13EA922F569EQ34975076-1E5A3FC2-0C98-462B-8DC9-3AFCD96AB9A9Q35163997-75DC44D1-1F61-4A73-A9B0-2C3911FC423AQ35525289-C4C18C3E-ED5E-4682-830D-2717EC92368DQ35533941-BD356D50-B659-4BE0-91B3-B6531CCCAFD9Q35548581-7FE88004-CC73-4DB7-9A0A-291E9782625EQ35596498-512966A8-EAB5-4C18-B90F-B1C688E7FB3EQ35658422-771610F3-1C85-4F59-B4EA-BA218F01BA58Q35801994-C3686ABE-77E8-4829-B47D-AC34C98B352AQ35967713-D22BF921-D7B7-4F5A-8AC1-408541B0C1B9Q36128243-30216F71-A7AE-4A97-BA8A-0D1959FBD3F8Q36539114-E48929D1-E3B7-4847-B839-FCAF5B616186Q36874295-A16B7054-611F-40A5-A469-1EA679EB5136Q36911270-6BF6D607-E0A4-4245-925F-A84C207112E9Q37309218-5A4C7331-D638-4EA3-BC17-992D59A9D0B9Q37855817-CE40737D-0346-4FD4-88F8-4C509B4DB969Q42937916-AB0D9035-32E0-499E-A219-8ACBE03B83C1
P2860
Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197
description
1985 nî lūn-bûn
@nan
1985 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@ast
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@en
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@nl
type
label
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@ast
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@en
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@nl
prefLabel
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@ast
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@en
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@nl
P2093
P2860
P356
P1476
Immunogens consisting of oligo ...... id or the toxin protein CRM197
@en
P2093
M E Pichichero
P Anderson
P2860
P356
10.1172/JCI111976
P407
P577
1985-07-01T00:00:00Z